The primary feature of stepper motors is listed right within their name: their ability to ‘step’ forwards and backwards, ...

A phase 3 prostate cancer trial of Candel Therapeutics' oncolytic virus has met its primary endpoint, sending the stock up more than 200%. The phase 3 hit was however offset by the failure of a ...

--(BUSINESS WIRE)--Veradermics ... "The initiation of our pivotal Phase 2/3 clinical trial in hair loss and completion of this $75 million financing marks a significant milestone for Veradermics.

IIT Kanpur's 2024-25 batch received 1,109 job offers in the first placement phase, with 1,035 accepted. A 27% rise in international offers was noted. Indian Institute of Technology (IIT ...

Hamas officials told AFP that the current framework for a deal would see the implementation of a ceasefire and the gradual release of hostages over three phases. In the first, six-week phase ...

Set to release on Friday, December 13, Mismatched Season 3 has not aired online (as of 11:15 AM). Netflix has defined the new season of the Rohit Saraf-Prajakta Koli starrer as a “new phase of ...

Candel Therapeutics’s stock has soared by 172% after its Phase III trial evaluating CAN-2409, a viral immunotherapy in localised prostate cancer patients, met its primary endpoint. Researchers ...

TOKYO--(BUSINESS WIRE)--Aurion Biotech ... we look forward to bringing the high dose of AURN001 forward into our proposed Phase 3 pivotal trials.” “We believe that today’s news is another ...

Nvidia led the first phase of the artificial intelligence boom, but cloud computing and software companies could be the next big winners. Morgan Stanley analysts recently upgraded Cloudflare stock ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

Fashion label Phase Eight's Boxing Day sale is in full swing, offering customers up to 60% off. The premium high street brand usually carries items priced £100 or more, making this event a ...

After reviewing data from the first part of a phase 1/2 trial of its oral RNR inhibitor ... and our novel ecDTx 3 program, where we’ve made substantial preclinical progress and expect to ...